4.6 Article

Enhanced production of C5 dicarboxylic acids by aerobic-anaerobic shift in fermentation of engineered Escherichia coli

期刊

PROCESS BIOCHEMISTRY
卷 62, 期 -, 页码 53-58

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.procbio.2017.09.001

关键词

CS dicarboxylic acids; Synthetic biology; Metabolic engineering; Aerobic-anaerobic shift fermentation; Anaerobically-inducible promoter

资金

  1. National Natural Science Foundation of China [21406138, 31370083]
  2. Program of Shanghai Subject Chief Scientist from the Science and Technology Commission of Shanghai Municipality [14XD1402600]
  3. National Basic Research Program of China [2013CB733903]
  4. Open Funding Project of the State Key Laboratory of Bioreactor Engineering

向作者/读者索取更多资源

Synthetic biology provides a significant platform in creating novel pathways/organisms for producing useful compounds, while it remains a challenge to enhance the production efficiency. Recently we constructed a recombinant Escherichia coli for glutarate production using a synthetic alpha-ketoacid reduction pathway, in which aketoglutarate is reduced to 2-hydroxyglutarate then converted to glutarate. However, the production titer was low, which may be due to 1) oxygen-sensitive nature of 2-hydroxyglutaryl-CoA dehydratase (HgdABC) and 2) limited cell growth in anaerobic cultivation. Therefore, we developed an aerobic-anaerobic two-stage strategy by growing more cells aerobically, then shifting to anaerobic cultivation to ensure the functional HgdABC for glutarate biosynthesis. The two-stage cultivation resulted in higher production of glutarate and other two C5 dicarboxylic acids glutaconate and 2-hydroxylglutarate than the original anaerobic process. Furthermore, we used an anaerobically-inducible nar promoter to improve the hgdABC expression responding to aerobic-anaerobic shift. Finally, the glutarate, glutaconate and 2-hydroxyglutarate titer was increased about 2, 5 and 3 times, reaching 11.6, 108.8 and 399.5 mg/L, respectively. The work demonstrated an effective strategy for ameliorating a-ketoacid reduction pathway to produce C5 dicarboxylic acids, as well as the potential of integration of bioprocess and metabolic engineering for enhancing chemicals production by an engineered microorganism.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据